Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways

• প্রধান লেখক: Ligang Wang (লেখক), Ying Wang (লেখক), Qiqi Xie (লেখক), Songcheng Xu (লেখক), Chen Yang (লেখক), Fei Liu (লেখক), Yang Liu (লেখক), Fuwei Wang (লেখক), Weinan Chen (লেখক), Jianchun Li (লেখক), Litao Sun (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2024-12-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

RCC is a malignant tumor arising from the urothelium of renal parenchyma that remains challenging to be treated. In this study, we assessed the anti-tumor effects of Resveratrol liposomes (RES-lips) combined with sorafenib on renal cell carcinoma (RCC) and explored the potential mechanisms underlyin...